Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × Bevacizumab × Clear all

NCT00398320 2017-03-01

Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Phase 2 Completed

40 enrolled 9 charts

Neuroendocrine Tumors

NCT00137774 2013-04-09

Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

Phase 2 Completed

Neuroendocrine Tumors

NCT01203306 2010-09-16

XELBEVOCT

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors